What is group B streptococcus?
Group B streptococcus (GBS) are common bacteria that can be found in the
digestive tract, urinary tract, and genital area of adults. Although GBS
infection usually causes no problems in healthy women before pregnancy, it
can cause serious illness for the mother and baby during pregnancy and after
delivery.
Why is group B streptococcus a concern?
One out of every four or five pregnant women carries GBS in her
rectum or vagina. In the pregnant mother, GBS infection may cause
chorioamnionitis (a severe infection of the placental tissues) and
postpartum (after birth) infection. Urinary tract infections caused by GBS
can lead to preterm labor and birth.
Newborn babies can contract the GBS during pregnancy, or from the mother's
genital tract during labor and delivery. GBS is the most common cause of
life-threatening infections in newborns, including pneumonia and meningitis.
About one out of every 100 to 200 babies whose mothers carry GBS can develop
symptoms of GBS disease if the mother is untreated. Premature babies are more susceptible to GBS
infection than full-term babies.
How is group B streptococcus diagnosed?
GBS can be cultured from the mother's vagina or rectum with a swab during a
pelvic examination. GBS can also be cultured from a mother's urine. Cultures
are usually done between 35 and 37 weeks of pregnancy and may take a few
days to complete. Cultures collected earlier in pregnancy do not accurately
predict whether a mother will have GBS at delivery.
Treatment for group B streptococcus:
Specific treatment for GBS will be determined by your physician based on:
- your pregnancy, overall health, and medical history
- extent of the disease
- your tolerance for specific medications, procedures, or therapies
- expectations for the course of the disease
- your opinion or preference
A positive GBS culture means that the mother carries GBS. It does not
mean that she or her baby will definitely become ill. However, the decision
to treat GBS must be balanced with certain risk factors.
The Centers for Disease Control and Prevention (CDC) and the American
College of Obstetricians and Gynecologists (ACOG) recommend treating women
with positive GBS cultures with intravenous (IV) antibiotics during labor to
reduce the risk of transmission of the infection to the baby. Treatment may
also be needed for women with certain risk factors, including the following:
- fever during labor
- rupture of membranes (bag of waters) for 18 hours or longer
- labor or rupture of membranes before 37 weeks gestation
- history of GBS infection in a previous baby
How can group B streptococcus be prevented?
It is important to understand that, in spite of testing and treatment, some
babies still develop GBS disease. Research is ongoing to develop vaccines to
prevent GBS disease. (In the future, women who are vaccinated against GBS
may make antibodies that cross the placenta and protect the baby during
birth and early infancy.)